{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:38:18Z","timestamp":1788388698942,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T00:00:00Z","timestamp":1592956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ymgme.2020.06.010","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T11:41:14Z","timestamp":1592998874000},"page":"245-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Long-term efficacy of olipudase alfa in adults with acid sphingomyelinase deficiency (ASMD): Further clearance of hepatic sphingomyelin is associated with additional improvements in pro- and anti-atherogenic lipid profiles after 42\u00a0months of treatment"],"prefix":"10.1016","volume":"131","author":[{"given":"Beth L.","family":"Thurberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin H.","family":"Lachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa P.","family":"Wasserstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allena J.","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atef","family":"Zaher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Judith","family":"Peterschmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2020.06.010_bb0005","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1161\/01.ATV.20.12.2614","article-title":"Plasma sphingomyelin level as a risk factor for coronary artery disease","volume":"20","author":"Jiang","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymgme.2020.06.010_bb0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1743-7075-3-5","article-title":"Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease","volume":"3","author":"Schlitt","year":"2006","journal-title":"Nutr. Metab. (Lond.)"},{"issue":"3","key":"10.1016\/j.ymgme.2020.06.010_bb0015","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/ATVBAHA.109.199281","article-title":"Association of plasma sphingomyelin levels and incident coronary heart disease events in an adult population: multi ethnic study of atherosclerosis","volume":"30","author":"Yeboah","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymgme.2020.06.010_bb0020","unstructured":"Schuchman, E.H., and Desnick, R.J. 2013. Niemann-Pick Disease Types a and B: Acid Sphingomyelinase Deficiencies. In OMMBID-The Online Metabolic and Molecular Bases of Inherited Disease. D. Valle, A. Beaudet, B. Vogelstein, K. Kinzler, S. Antonarakis, A. Ballabio, K. Gibson, and G. Mitchell, editors. New York: McGraw Hill. http:\/\/ommbid.mhmedical.com\/content.aspx?bookid=474&Sectionid=45374145. Accessed May 2015."},{"key":"10.1016\/j.ymgme.2020.06.010_bb0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrg2481","article-title":"Plasma lipoproteins: genetic influences and clinical implications","volume":"10","author":"Hegele","year":"2009","journal-title":"Nat. Rev Genet."},{"key":"10.1016\/j.ymgme.2020.06.010_bb0030","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/CIRCRESAHA.114.300632","article-title":"Regulation of high-density lipoprotein metabolism","volume":"114","author":"Rye","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymgme.2020.06.010_bb0035","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0005-2760(83)90218-7","article-title":"Biochemical studies in Niemann-pick disease: major sphingolipids of liver and spleen","volume":"750","author":"Vanier","year":"1983","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2020.06.010_bb0040","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1194\/jlr.M500011-JLR200","article-title":"ESI-MS quantitation of increased SM in Niemann-pick disease type B HDL","volume":"46","author":"Lee","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2020.06.010_bb0045","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1194\/jlr.M500487-JLR200","article-title":"Increased SM content impairs HDL biogenesis and maturation in human Niemann-pick disease type B","volume":"47","author":"Lee","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2020.06.010_bb0050","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/jmg.27.8.499","article-title":"Very low levels of high density lipoprotein cholesterol in four sibs of a family with non-neuropathic Niemann-pick disease and sea-blue histiocytosis","volume":"27","author":"Viana","year":"1990","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2020.06.010_bb0055","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1210\/jc.2012-2185","article-title":"Approach to the patient with extremely low HDL-cholesterol","volume":"97","author":"Rader","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2020.06.010_bb0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bbalip.2014.07.015","article-title":"HDL and atherosclerosis: insights from inherited HDL disorders","author":"Calabresi","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2020.06.010_bb0065","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1365-2559.2006.02355.x","article-title":"Pulmonary involvement by Niemann-pick disease. A report of six cases","volume":"48","author":"Nicholson","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.ymgme.2020.06.010_bb0070","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/aje\/kwj140","article-title":"Plasma sphingomyelin and subclinical atherosclerosis: findings from the multi-ethnic study of atherosclerosis","volume":"163","author":"Nelson","year":"2006","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ymgme.2020.06.010_bb0075","first-page":"149","article-title":"Sphingolipids: major regulators of lipid metabolism","volume":"10","author":"Worgall","year":"2007","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.ymgme.2020.06.010_bb0080","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1161\/ATVBAHA.113.301736","article-title":"C-reactive protein, fatal and nonfatal coronary artery disease, stroke, and peripheral artery disease in the prospective EPIC-Norfolk cohort study","volume":"33","author":"Van Wijk","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymgme.2020.06.010_bb0085","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1111\/bph.12616","article-title":"C-reactive protein promotes atherosclerosis by increasing LDL transcytosis across endothelial cells","volume":"171","author":"Bian","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ymgme.2020.06.010_bb0090","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1053\/euhj.2000.2148","article-title":"Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality","volume":"21","author":"Erikssen","year":"2000","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ymgme.2020.06.010_bb0095","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0195-668X(02)00741-8","article-title":"Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality","volume":"24","author":"Natali","year":"2003","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ymgme.2020.06.010_bb0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jpeds.2004.02.048","article-title":"Lipid abnormalities in children with types a and B Niemann-pick disease","volume":"145","author":"McGovern","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2020.06.010_bb0105","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s10545-006-0226-y","article-title":"Acid sphingomyelinase deficiency: cardiac dysfunction and characteristic findings of the coronary arteries","volume":"29","author":"Ishii","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2020.06.010_bb0110","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/gim.2013.4","article-title":"Morbidity and mortality in type B Niemann-pick disease","volume":"15","author":"McGovern","year":"2013","journal-title":"Genet Med"},{"key":"10.1016\/j.ymgme.2020.06.010_bb0115","first-page":"117","article-title":"Cirrhosis and liver failure: expanding phenotype of acid sphingomyelinase-deficient Niemann-pick disease in adulthood","volume":"15","author":"Lidove","year":"2015","journal-title":"JIMD Rep"},{"key":"10.1016\/j.ymgme.2020.06.010_bb0120","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ymgme.2013.11.012","article-title":"Lyso-sphingomyelin is elevated in dried blood spots of Niemann-pick B patients","volume":"111","author":"Chuang","year":"2014","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2020.06.010_bb0125","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s10545-017-0123-6","article-title":"Olipudase alfa for treatment of acid sphingomyelinase deficiency (ASMD): safety and efficacy in adults treated for 30 months","volume":"41","author":"Wasserstein","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2020.06.010_bb0130","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/PAS.0b013e31825793ff","article-title":"Liver and skin histopathology in adults with acid sphingomyelinase deficiency (Niemann-Pick disease type B)","volume":"36","author":"Thurberg","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ymgme.2020.06.010_bb0135","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ymgme.2015.05.013","article-title":"Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency","volume":"116","author":"Wasserstein","year":"2015","journal-title":"Mol Genet Met"},{"issue":"9","key":"10.1016\/j.ymgme.2020.06.010_bb0140","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1097\/PAS.0000000000000659","article-title":"Clearance of hepatic Sphingomyelin by Olipudase Alfa is associated with improvement in lipid profiles in acid Sphingomyelinase deficiency","volume":"40","author":"Thurberg","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ymgme.2020.06.010_bb0145","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies","volume":"79","author":"Gordon","year":"1989","journal-title":"Circulation."},{"key":"10.1016\/j.ymgme.2020.06.010_bb0150","first-page":"620","article-title":"Optimization of a histopathological biomarker for sphingomyelin accumulation in Niemann-pick B disease","volume":"60","author":"Taksir","year":"2012","journal-title":"J Histochem Biochem"},{"key":"10.1016\/j.ymgme.2020.06.010_bb0155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/002215540505300108","article-title":"High resolution light microscopy (HRLM) and digital analysis of Pompe disease pathology","volume":"53","author":"Lynch","year":"2005","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.ymgme.2020.06.010_bb0160","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1194\/jlr.M500357-JLR200","article-title":"Absorption and lipoprotein transport of sphingomyelin","volume":"47","author":"Nilsson","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ymgme.2020.06.010_bb0165","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1388-1981(02)00365-7","article-title":"Effects of sphingomyelin on apolipoprotein E and lipoprotein lipase-mediated cell uptake of lipid particles","volume":"1631","author":"Morita","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2020.06.010_bb0170","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0022-2275(20)34210-3","article-title":"Effects of sphingomyelin and cholesterol on lipoprotein lipase-mediated lipolysis in lipid emulsions","volume":"39","author":"Arimoto","year":"1998","journal-title":"J. Lipid Res."},{"issue":"32","key":"10.1016\/j.ymgme.2020.06.010_bb0175","doi-asserted-by":"crossref","first-page":"19152","DOI":"10.1074\/jbc.271.32.19152","article-title":"Sphingomyelin inhibits the lecithin-cholesterol acyltransferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding","author":"Bolin","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ymgme.2020.06.010_bb0180","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1515\/cclm-2016-0340","article-title":"Diagnosis of sphingolipidoses: a new simultaneous measurement of lysosphingolipids by LC-MS\/MS","volume":"55","author":"Polo","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ymgme.2020.06.010_bb0185","series-title":"Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. Robert D Odze Et Al. Eds. Philadelphia, Saunders","first-page":"739","article-title":"Chap 32: Liver tissue processing techniques","author":"Antonio","year":"2004"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719220301499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719220301499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:26:16Z","timestamp":1761089176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719220301499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":37,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1096719220301499"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.06.010","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term efficacy of olipudase alfa in adults with acid sphingomyelinase deficiency (ASMD): Further clearance of hepatic sphingomyelin is associated with additional improvements in pro- and anti-atherogenic lipid profiles after 42\u00a0months of treatment","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}